Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02505841Unknown
Randomised trial of ropivacaine in postoperative pain (3 arms), sponsored by CHU Montpellier. Primary endpoint: Painkiller of help consumption at 24 hours. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02505841.